Hearing loss: The final frontier of pharmacology
Abstract Despite a prevalence greater than cancer or diabetes, there are no currently approved drugs for the treatment of hearing loss. Research over the past two decades has led to a vastly improved understanding of the cellular and molecular mechanisms in the cochlea that lead to hearing deficits...
Saved in:
Main Authors: | Alan C. Foster (Author), Bonnie E. Jacques (Author), Fabrice Piu (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting the Microenvironment in MDS: The Final Frontier
by: Patric Teodorescu, et al.
Published: (2020) -
Neoadjuvant personalized cancer vaccines: the final frontier?
by: Guilhem Richard, et al.
Published: (2024) -
HIV persistence in the CNS: the final frontier for a cure?
by: S.h.a.r.o.n.R. Lewin, et al.
Published: (2016) -
Trajectory of hearing loss in children with unilateral hearing loss
by: Elizabeth M. Fitzpatrick, et al.
Published: (2023) -
Hearing Loss
Published: (2012)